{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:20Z","timestamp":1793826020018,"version":"4.6.1"},"reference-count":126,"publisher":"American Medical Association (AMA)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,11,28]]},"abstract":"<jats:sec id=\"ab-jrv230020-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Obesity affects approximately 42% of US adults and is associated with increased rates of type 2 diabetes, hypertension, cardiovascular disease, sleep disorders, osteoarthritis, and premature death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv230020-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>\n                      A body mass index (BMI) of 25 or greater is commonly used to define overweight, and a BMI of 30 or greater to define obesity, with lower thresholds for Asian populations (BMI \u226525-27.5), although use of BMI alone is not recommended to determine individual risk. Individuals with obesity have higher rates of incident cardiovascular disease. In men with a BMI of 30 to 39, cardiovascular event rates are 20.21 per 1000 person-years compared with 13.72 per 1000 person-years in men with a normal BMI. In women with a BMI of 30 to 39.9, cardiovascular event rates are 9.97 per 1000 person-years compared with 6.37 per 1000 person-years in women with a normal BMI. Among people with obesity, 5% to 10% weight loss improves systolic blood pressure by about 3 mm Hg for those with hypertension, and may decrease hemoglobin A\n                      <jats:sub>1c<\/jats:sub>\n                      by 0.6% to 1% for those with type 2 diabetes. Evidence-based obesity treatment includes interventions addressing 5 major categories: behavioral interventions, nutrition, physical activity, pharmacotherapy, and metabolic\/bariatric procedures. Comprehensive obesity care plans combine appropriate interventions for individual patients. Multicomponent behavioral interventions, ideally consisting of at least 14 sessions in 6 months to promote lifestyle changes, including components such as weight self-monitoring, dietary and physical activity counseling, and problem solving, often produce 5% to 10% weight loss, although weight regain occurs in 25% or more of participants at 2-year follow-up. Effective nutritional approaches focus on reducing total caloric intake and dietary strategies based on patient preferences. Physical activity without calorie reduction typically causes less weight loss (2-3 kg) but is important for weight-loss maintenance. Commonly prescribed medications such as antidepressants (eg, mirtazapine, amitriptyline) and antihyperglycemics such as glyburide or insulin cause weight gain, and clinicians should review and consider alternatives. Antiobesity medications are recommended for nonpregnant patients with obesity or overweight and weight-related comorbidities in conjunction with lifestyle modifications. Six medications are currently approved by the US Food and Drug Administration for long-term use: glucagon-like peptide receptor 1 (GLP-1) agonists (semaglutide and liraglutide only), tirzepatide (a glucose-dependent insulinotropic polypeptide\/GLP-1 agonist), phentermine-topiramate, naltrexone-bupropion, and orlistat. Of these, tirzepatide has the greatest effect, with mean weight loss of 21% at 72 weeks. Endoscopic procedures (ie, intragastric balloon and endoscopic sleeve gastroplasty) can attain 10% to 13% weight loss at 6 months. Weight loss from metabolic and bariatric surgeries (ie, laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) ranges from 25% to 30% at 12 months. Maintaining long-term weight loss is difficult, and clinical guidelines support the use of long-term antiobesity medications when weight maintenance is inadequate with lifestyle interventions alone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv230020-3\">\n                    <jats:title>Conclusion and Relevance<\/jats:title>\n                    <jats:p>Obesity affects approximately 42% of adults in the US. Behavioral interventions can attain approximately 5% to 10% weight loss, GLP-1 agonists and glucose-dependent insulinotropic polypeptide\/GLP-1 receptor agonists can attain approximately 8% to 21% weight loss, and bariatric surgery can attain approximately 25% to 30% weight loss. Comprehensive, evidence-based obesity treatment combines behavioral interventions, nutrition, physical activity, pharmacotherapy, and metabolic\/bariatric procedures as appropriate for individual patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.19897","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T11:02:06Z","timestamp":1701169326000},"page":"2000","source":"Crossref","is-referenced-by-count":771,"title":["Obesity Management in Adults"],"prefix":"10.1001","volume":"330","author":[{"given":"Arielle","family":"Elmaleh-Sachs","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine and Clinical Innovation, New York University Grossman School of Medicine, New York, New York"},{"name":"Department of Population Health, New York University Grossman School of Medicine, New York, New York"},{"name":"Family Health Centers at NYU Langone, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn T.","family":"Bramante","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Minnesota Medical School, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinda M.","family":"Nicklas","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Gudzune","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Jay","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine and Clinical Innovation, New York University Grossman School of Medicine, New York, New York"},{"name":"Department of Population Health, New York University Grossman School of Medicine, New York, New York"},{"name":"New York Harbor Veteran Affairs, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"360","key":"jrv230020r2","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017-2018.","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"3","key":"jrv230020r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247307","article-title":"Association of body mass index with health care expenditures in the United States by age and sex.","volume":"16","author":"Ward","year":"2021","journal-title":"PLoS One"},{"key":"jrv230020r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive clinical practice guidelines for medical care of patients with obesity.","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"25","key":"jrv230020r5","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Obesity Society.","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"31","key":"jrv230020r6","doi-asserted-by":"publisher","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline.","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ"},{"issue":"6","key":"jrv230020r7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/osp4.v8.6","article-title":"A systematic review of obesity as a barrier to accessing cancer screening services.","volume":"8","author":"Graham","year":"2022","journal-title":"Obes Sci Pract"},{"issue":"2","key":"jrv230020r8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over.","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr Obes Rep"},{"issue":"12","key":"jrv230020r9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery.","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"jrv230020r10","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity.","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"key":"jrv230020r11","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.2337\/dc22-S008","article-title":"Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes\u20142022.","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"2","key":"jrv230020r12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline.","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"jrv230020r13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"10026","key":"jrv230020r15","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants.","volume":"387","author":"NCD Risk Factor Collaboration","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"jrv230020r16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.7326\/M22-0609","article-title":"Heterogeneity in obesity prevalence among Asian American adults.","volume":"175","author":"Shah","year":"2022","journal-title":"Ann Intern Med"},{"issue":"25","key":"jrv230020r17","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity.","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"key":"jrv230020r18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.metabol.2018.12.012","article-title":"The pathogenesis of obesity.","volume":"92","author":"Oussaada","year":"2019","journal-title":"Metabolism"},{"issue":"2","key":"jrv230020r19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: from discovery to biology.","volume":"23","author":"Loos","year":"2022","journal-title":"Nat Rev Genet"},{"key":"jrv230020r20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/epirev\/mxp005","article-title":"Built environments and obesity in disadvantaged populations.","volume":"31","author":"Lovasi","year":"2009","journal-title":"Epidemiol Rev"},{"issue":"3","key":"jrv230020r21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"jrv230020r22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s13679-020-00398-7","article-title":"Socioeconomics of obesity.","volume":"9","author":"Anekwe","year":"2020","journal-title":"Curr Obes Rep"},{"issue":"3","key":"jrv230020r23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity.","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv230020r24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cnur.2021.08.001","article-title":"Pathophysiology of obesity.","volume":"56","author":"Kessler","year":"2021","journal-title":"Nurs Clin North Am"},{"issue":"4","key":"jrv230020r25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity.","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"jrv230020r26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.metabol.2018.11.009","article-title":"Metabolically healthy versus metabolically unhealthy obesity.","volume":"92","author":"Iacobini","year":"2019","journal-title":"Metabolism"},{"issue":"24","key":"jrv230020r27","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1001\/jama.2018.19329","article-title":"Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors.","volume":"320","author":"Lotta","year":"2018","journal-title":"JAMA"},{"key":"jrv230020r28","article-title":"Obesity: preventing and managing the global epidemic: report of a WHO consultation.","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"14","key":"jrv230020r30","doi-asserted-by":"publisher","first-page":"E1059","DOI":"10.1503\/cmaj.110387","article-title":"Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity.","volume":"183","author":"Padwal","year":"2011","journal-title":"CMAJ"},{"issue":"1","key":"jrv230020r31","doi-asserted-by":"publisher","first-page":"115.e1","DOI":"10.1016\/j.amjmed.2015.07.015","article-title":"An evidence-based guide for obesity treatment in primary care.","volume":"129","author":"Fitzpatrick","year":"2016","journal-title":"Am J Med"},{"issue":"14","key":"jrv230020r33","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1001\/jama.289.14.1747","article-title":"Weight loss counseling revisited.","volume":"289","author":"Serdula","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"jrv230020r34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/oby.v29.5","article-title":"Weight can\u2019t wait: a guide to discussing obesity and organizing treatment in the primary care setting.","volume":"29","author":"Gallagher","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"jrv230020r35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1472-6963-10-159","article-title":"Physicians\u2019 use of the 5As in counseling obese patients: is the quality of counseling associated with patients\u2019 motivation and intention to lose weight?","volume":"10","author":"Jay","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"jrv230020r36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ypmed.2014.02.001","article-title":"Perceived judgment about weight can negatively influence weight loss: a cross-sectional study of overweight and obese patients.","volume":"62","author":"Gudzune","year":"2014","journal-title":"Prev Med"},{"issue":"4","key":"jrv230020r37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/obr.2015.16.issue-4","article-title":"Impact of weight bias and stigma on quality of care and outcomes for patients with obesity.","volume":"16","author":"Phelan","year":"2015","journal-title":"Obes Rev"},{"issue":"1","key":"jrv230020r38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13679-023-00493-5","article-title":"a call to reconceptualize obesity treatment in service of health equity: review of evidence and future directions.","volume":"12","author":"Herbozo","year":"2023","journal-title":"Curr Obes Rep"},{"issue":"6","key":"jrv230020r39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/jhn.2016.29.issue-6","article-title":"Setting targets leads to greater long-term weight losses and \u201cunrealistic\u201d targets increase the effect in a large community-based commercial weight management group.","volume":"29","author":"Avery","year":"2016","journal-title":"J Hum Nutr Diet"},{"issue":"19","key":"jrv230020r40","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The Physical Activity Guidelines for Americans.","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"jrv230020r41","first-page":"164","article-title":"Naltrexone\/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.","volume":"41","author":"Sherman","year":"2016","journal-title":"P T"},{"issue":"3","key":"jrv230020r42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv230020r43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jama.2017.20897","article-title":"Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial.","volume":"319","author":"Peterli","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"jrv230020r44","doi-asserted-by":"publisher","first-page":"ITC65","DOI":"10.7326\/AITC202205170","article-title":"Care of the patient after metabolic and bariatric surgery.","volume":"175","author":"Bramante","year":"2022","journal-title":"Ann Intern Med"},{"issue":"5","key":"jrv230020r45","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.soard.2016.12.018","article-title":"American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients.","volume":"13","author":"Parrott","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"jrv230020r46","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/oby.22769","article-title":"Weight change 2 years after termination of the intensive lifestyle intervention in the Look AHEAD study.","volume":"28","author":"Chao","year":"2020","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"jrv230020r47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140065","article-title":"Dietary interventions for obesity: clinical and mechanistic findings.","volume":"131","author":"Chao","year":"2021","journal-title":"J Clin Invest"},{"issue":"7","key":"jrv230020r49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/M14-2238","article-title":"Efficacy of commercial weight-loss programs: an updated systematic review.","volume":"162","author":"Gudzune","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"jrv230020r50","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/jama.2014.10397","article-title":"Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis.","volume":"312","author":"Johnston","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"jrv230020r51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13679-021-00428-y","article-title":"Commercial weight loss programs in the management of obesity: an update.","volume":"10","author":"Laudenslager","year":"2021","journal-title":"Curr Obes Rep"},{"issue":"12","key":"jrv230020r52","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The Diabetes Prevention Program (DPP): description of lifestyle intervention.","volume":"25","author":"Diabetes Prevention Program Research Group","year":"2002","journal-title":"Diabetes Care"},{"issue":"11","key":"jrv230020r53","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.2105\/AJPH.2015.302641","article-title":"A randomized comparative effectiveness trial for preventing type 2 diabetes.","volume":"105","author":"Ackermann","year":"2015","journal-title":"Am J Public Health"},{"issue":"11","key":"jrv230020r54","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"jrv230020r55","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci20-0018","article-title":"Cost-effectiveness of diabetes prevention interventions targeting high-risk individuals and whole populations: a systematic review.","volume":"43","author":"Zhou","year":"2020","journal-title":"Diabetes Care"},{"key":"jrv230020r57","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.2147\/DMSO.S272802","article-title":"Effects of plant-based diets on weight status: a systematic review.","volume":"13","author":"Tran","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"23","key":"jrv230020r58","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1161\/CIR.0000000000001031","article-title":"2021 Dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association.","volume":"144","author":"Lichtenstein","year":"2021","journal-title":"Circulation"},{"key":"jrv230020r59","doi-asserted-by":"publisher","first-page":"m696","DOI":"10.1136\/bmj.m696","article-title":"Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials.","volume":"369","author":"Ge","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"jrv230020r60","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/nutrit\/nuaa044","article-title":"Effects of macronutrient intake in obesity: a meta-analysis of low-carbohydrate and low-fat diets on markers of the metabolic syndrome.","volume":"79","author":"Willems","year":"2021","journal-title":"Nutr Rev"},{"issue":"5","key":"jrv230020r61","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2337\/dc18-0836","article-title":"Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial.","volume":"42","author":"Salas-Salvad\u00f3","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"jrv230020r62","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.amepre.2018.01.029","article-title":"Systematic review of behavioral weight management program MOVE! for veterans.","volume":"54","author":"Maciejewski","year":"2018","journal-title":"Am J Prev Med"},{"issue":"2","key":"jrv230020r63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ecl.2020.02.006","article-title":"Role of commercial weight-loss programs in medical management of obesity.","volume":"49","author":"Gudzune","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"jrv230020r64","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.2018.7777","article-title":"Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"320","author":"LeBlanc","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"jrv230020r65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.v1519.1","article-title":"Connecting insufficient sleep and insomnia with metabolic dysfunction.","volume":"1519","author":"Duan","year":"2023","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"jrv230020r66","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv230020r67","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/obr.v20.2","article-title":"Determinants of weight loss maintenance: a systematic review.","volume":"20","author":"Varkevisser","year":"2019","journal-title":"Obes Rev"},{"issue":"12","key":"jrv230020r68","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/oby.2007.368","article-title":"Consistent self-monitoring of weight: a key component of successful weight loss maintenance.","volume":"15","author":"Butryn","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"jrv230020r69","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/obr.v20.4","article-title":"A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss.","volume":"20","author":"Astbury","year":"2019","journal-title":"Obes Rev"},{"issue":"12","key":"jrv230020r70","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39558","article-title":"Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized clinical trials.","volume":"4","author":"Patikorn","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"jrv230020r71","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.orcp.2021.01.008","article-title":"Impact of portion-control plates (PCP) on weight reduction: a systematic review and meta-analysis of intervention studies.","volume":"15","author":"Jayawardena","year":"2021","journal-title":"Obes Res Clin Pract"},{"issue":"7","key":"jrv230020r72","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/nu12072005","article-title":"Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: a meta-analysis of randomized controlled trials.","volume":"12","author":"Choi","year":"2020","journal-title":"Nutrients"},{"key":"jrv230020r73","doi-asserted-by":"publisher","DOI":"10.1111\/obr.v22.S4","article-title":"Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group.","volume":"22","author":"Oppert","year":"2021","journal-title":"Obes Rev"},{"key":"jrv230020r74","doi-asserted-by":"publisher","DOI":"10.1111\/obr.v22.S4","article-title":"Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies.","volume":"22","author":"Bellicha","year":"2021","journal-title":"Obes Rev"},{"issue":"4","key":"jrv230020r75","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pcad.2014.10.003","article-title":"Strategies for promoting physical activity in clinical practice.","volume":"57","author":"Sallis","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"jrv230020r76","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1016\/S2589-7500(22)00111-X","article-title":"Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses.","volume":"4","author":"Ferguson","year":"2022","journal-title":"Lancet Digit Health"},{"key":"jrv230020r77","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/DMSO","article-title":"Medications that cause weight gain and alternatives in Canada: a narrative review.","volume":"11","author":"Wharton","year":"2018","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"jrv230020r78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13679-020-00419-5","article-title":"Drugs affecting body weight, body fat distribution, and metabolic function\u2014mechanisms and possible therapeutic or preventive measures: an update.","volume":"10","author":"Verhaegen","year":"2021","journal-title":"Curr Obes Rep"},{"issue":"1","key":"jrv230020r79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/13651501.2018.1449864","article-title":"Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials.","volume":"23","author":"Goh","year":"2019","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"1","key":"jrv230020r80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.","volume":"16","author":"de Silva","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"11","key":"jrv230020r81","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity.","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"jrv230020r82","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/dom.v24.8","article-title":"Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: a meta-analysis of placebo-controlled randomized trials.","volume":"24","author":"Leite","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"jrv230020r83","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/oby.v21.11","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults.","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"jrv230020r84","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/oby.v29.6","article-title":"Efficacy and safety of phentermine\/topiramate in adults with overweight or obesity: a systematic review and meta-analysis.","volume":"29","author":"Lei","year":"2021","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"jrv230020r85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management.","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv230020r86","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.mcna.2018.02.008","article-title":"Pharmacotherapy for alcohol use disorder.","volume":"102","author":"Holt","year":"2018","journal-title":"Med Clin North Am"},{"issue":"9123","key":"jrv230020r87","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients.","volume":"352","author":"Sj\u00f6str\u00f6m","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"jrv230020r88","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ijo.2009.124","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.","volume":"33","author":"Cercato","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"10403","key":"jrv230020r89","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0140-6736(23)01185-6","article-title":"Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"402","author":"Knop","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"jrv230020r90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9662","key":"jrv230020r91","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","article-title":"Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.","volume":"373","author":"Garber","year":"2009","journal-title":"Lancet"},{"issue":"9","key":"jrv230020r92","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/oby.2001.71","article-title":"Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.","volume":"9","author":"Gadde","year":"2001","journal-title":"Obes Res"},{"issue":"10","key":"jrv230020r93","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7326\/M18-1605","article-title":"Long-term weight loss with metformin or lifestyle intervention in the Diabetes Prevention Program Outcomes Study.","volume":"170","author":"Apolzan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"jrv230020r94","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11883-016-0568-3","article-title":"Metformin: an old therapy that deserves a new indication for the treatment of obesity.","volume":"18","author":"Igel","year":"2016","journal-title":"Curr Atheroscler Rep"},{"issue":"14","key":"jrv230020r96","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial.","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"9","key":"jrv230020r97","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/obr.v20.9","article-title":"Management of overweight and obesity in primary care\u2014a systematic overview of international evidence-based guidelines.","volume":"20","author":"Semlitsch","year":"2019","journal-title":"Obes Rev"},{"issue":"3","key":"jrv230020r98","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13679-019-00350-4","article-title":"Mechanism of glucagon-like peptide 1 improvements in type 2 diabetes mellitus and obesity.","volume":"8","author":"Nolen-Doerr","year":"2019","journal-title":"Curr Obes Rep"},{"issue":"14","key":"jrv230020r99","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial.","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"8","key":"jrv230020r100","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.v24.8","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension.","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"jrv230020r101","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s12325-022-02394-w","article-title":"GLP-1 agonists for weight loss: pharmacology and clinical implications.","volume":"40","author":"Moore","year":"2023","journal-title":"Adv Ther"},{"issue":"7","key":"jrv230020r102","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/a-1844-1176","article-title":"The antiobesity effect and safety of GLP-1 receptor agonist in overweight\/obese patients without diabetes: a systematic review and meta-analysis.","volume":"54","author":"Guo","year":"2022","journal-title":"Horm Metab Res"},{"key":"jrv230020r103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes.","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"jrv230020r104","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity.","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv230020r105","doi-asserted-by":"publisher","DOI":"10.1111\/obr.v24.3","article-title":"Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials.","volume":"24","author":"Alkhezi","year":"2023","journal-title":"Obes Rev"},{"issue":"8","key":"jrv230020r106","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1517\/14656566.2015.1041505","article-title":"Combination phentermine and topiramate extended release in the management of obesity.","volume":"16","author":"Alfaris","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"jrv230020r107","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP).","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"jrv230020r108","doi-asserted-by":"publisher","DOI":"10.1111\/obr.v22.11","article-title":"Clinical outcomes associated with anti-obesity medications in real-world practice: a systematic literature review.","volume":"22","author":"Ahmad","year":"2021","journal-title":"Obes Rev"},{"issue":"10321","key":"jrv230020r109","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0140-6736(21)01640-8","article-title":"Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.","volume":"399","author":"Shi","year":"2022","journal-title":"Lancet"},{"issue":"9741","key":"jrv230020r110","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"jrv230020r111","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/oby.v21.5","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II).","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"jrv230020r112","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/oby.2019.27.issue-2","article-title":"A randomized, double-blind, placebo-controlled study of gelesis100: a novel nonsystemic oral hydrogel for weight loss.","volume":"27","author":"Greenway","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"jrv230020r114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.2014.1311.issue-1","article-title":"Update on obesity pharmacotherapy.","volume":"1311","author":"Bray","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"jrv230020r115","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jama.2021.9486","article-title":"Progress in pharmacotherapy for obesity.","volume":"326","author":"Yanovski","year":"2021","journal-title":"JAMA"},{"key":"jrv230020r116","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.metabol.2018.10.010","article-title":"Pharmacotherapy of obesity: available medications and drugs under investigation.","volume":"92","author":"Pilitsi","year":"2019","journal-title":"Metabolism"},{"issue":"3","key":"jrv230020r117","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ijo.2016.229","article-title":"Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial.","volume":"41","author":"Courcoulas","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"jrv230020r118","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/jcm12031126","article-title":"Updates in endoscopic bariatric and metabolic therapies.","volume":"12","author":"Qureshi","year":"2023","journal-title":"J Clin Med"},{"issue":"10350","key":"jrv230020r119","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0140-6736(22)01280-6","article-title":"Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial.","volume":"400","author":"Abu Dayyeh","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"jrv230020r120","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s11695-019-04235-2","article-title":"Systematic review and meta-analysis of randomised controlled trials comparing long-term outcomes of Roux-en-Y gastric bypass and sleeve gastrectomy.","volume":"30","author":"Sharples","year":"2020","journal-title":"Obes Surg"},{"issue":"1","key":"jrv230020r121","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2018-000219","article-title":"Early and late complications of bariatric operation.","volume":"3","author":"Lim","year":"2018","journal-title":"Trauma Surg Acute Care Open"},{"issue":"3","key":"jrv230020r122","first-page":"179","article-title":"Do the five A\u2019s work when physicians counsel about weight loss?","volume":"43","author":"Alexander","year":"2011","journal-title":"Fam Med"},{"issue":"10","key":"jrv230020r123","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jama.299.10.1139","article-title":"Comparison of strategies for sustaining weight loss: the Weight Loss Maintenance randomized controlled trial.","volume":"299","author":"Svetkey","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"jrv230020r124","doi-asserted-by":"publisher","first-page":"222S","DOI":"10.1093\/ajcn\/82.1.222S","article-title":"Long-term weight loss maintenance.","volume":"82","author":"Wing","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"jrv230020r125","doi-asserted-by":"publisher","DOI":"10.1111\/obr.v21.5","article-title":"Successful weight loss maintenance: a systematic review of weight control registries.","volume":"21","author":"Paix\u00e3o","year":"2020","journal-title":"Obes Rev"},{"issue":"2","key":"jrv230020r126","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13679-021-00425-1","article-title":"Use of weight loss medications in patients after bariatric surgery.","volume":"10","author":"Redmond","year":"2021","journal-title":"Curr Obes Rep"},{"key":"jrv230020r113","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012"},{"key":"jrv230020r1","unstructured":"World Health Organization. WHO acceleration plan to stop obesity. Updated July 3, 2023. Accessed August 24, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240075634"},{"key":"jrv230020r14","unstructured":"Department of Veterans Affairs; Department of Defense. VA\/DoD Clinical Practice Guideline for the Management of Adult Overweight and Obesity. Version 3.0. Published 2020. Accessed June 19, 2023. https:\/\/www.healthquality.va.gov\/guidelines\/CD\/obesity\/VADoDObesityCPGFinal5087242020.pdf"},{"key":"jrv230020r29","unstructured":"American Medical Association. AMA adopts new policy clarifying role of BMI as a measure in medicine. Updated June 14, 2023. Accessed July 17, 2023. https:\/\/www.ama-assn.org\/press-center\/press-releases\/ama-adopts-new-policy-clarifying-role-bmi-measure-medicine"},{"key":"jrv230020r32","unstructured":"Centers for Medicare & Medicaid Services. CMS Manual System publication 100-04: Medicare claims processing: transmittal 2421: intensive behavioral therapy for obesity. Published March 7, 2012. Accessed April 3, 2023. https:\/\/www.cms.gov\/Regulations-and-Guidance\/Guidance\/Transmittals\/downloads\/R2421CP.pdf"},{"key":"jrv230020r48","unstructured":"US Department of Agriculture; US Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. 9th ed. Published December 2020. Accessed April 3, 2023. https:\/\/www.dietaryguidelines.gov\/sites\/default\/files\/2021-03\/Dietary_Guidelines_for_Americans-2020-2025.pdf"},{"key":"jrv230020r56","unstructured":"Department of Veterans Affairs. MOVE! weight management program. Accessed July 14, 2023. https:\/\/www.move.va.gov\/MOVE\/vetworkbook.asp#fullworkbook"},{"key":"jrv230020r95","unstructured":"National Institute of Child Health and Human Development. Drugs and Lactation Database (LacMed). Published 2006. Accessed April 10, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2812316\/jama_elmalehsachs_2023_rv_230020_1701725531.74368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T17:00:39Z","timestamp":1701709239000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2812316"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":126,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,11,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.19897","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,28]]}}}